Medunik
NJ - Princeton
BiotechnologyFocus: Rare Disease Treatments
Medunik is a life sciences company focused on Rare Disease Treatments.
Rare Diseases
Open Jobs
0
Products & Portfolio (2)
NITISINONE
nitisinone
Post-LOE
ORAL · CAPSULE
Hydroxyphenylpyruvate Dioxygenase Inhibitors
2022
30
PHEBURANE
sodium phenylbutyrate
Peak
ORAL · PELLETS
pro-drug and is metabolized to phenylacetate. Phenylacetate is a metabolically-active compound that conjugates with glutamine via acetylation to form phenylacetylglutamine. Phenylacetylglutamine is excreted by the kidneys, hence providing an alternate vehicle for waste nitrogen excretion.
acute hyperammonemiawhich can be a life-threatening medical emergency
2022
30
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 2 approved products
Top TAs: Metabolic Diseases
Portfolio Health
Peak1 (50%)
Post-LOE1 (50%)
2 total products